Immunological Interaction Between the Host and Candida Albicans Biofilm

NCT01919931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 237

Last updated 2016-12-07

No results posted yet for this study

Summary

Candida albicans is one of the most common nosocomial infection and the onset relies on the host immune status. The purpose of this study is to determine the immunological profile of patients infected with Candida albicans, that could ideally lead to a strategy to identify patients who could benefit from prophylaxis.

Conditions

  • Candidiasis

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Adrian Liston, Group Leader · Flemish Institute of Biotechnology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-08-31
Completion
2016-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01919931 on ClinicalTrials.gov